中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [3]
采集方式
OAI收割 [3]
内容类型
期刊论文 [3]
发表日期
2023 [1]
2022 [2]
学科主题
筛选
浏览/检索结果:
共3条,第1-3条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 9
作者:
Li, Hua-ying
;
Chen, Yi-li
;
Deng, Xiang-nan
;
Li, Huan-huan
;
Tan, Jie
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2023/10/17
cancer immunotherapy
B7-H3
PD-L1
bispecific antibodies
VHH
antibody-dependent cell-mediated cytotoxicity (ADCC)
Development of a variant of dinutuximab with enhanced antitumor efficacy and reduced induction of neuropathic pain
期刊论文
OAI收割
FEBS OPEN BIO, 2022, 卷号: 12, 期号: 9, 页码: 1644-1656
作者:
Liu, Xin-Yuan
;
Chen, Yi-Li
;
Liu, Guo-Jian
;
Deng, Xiang-Nan
;
Cui, Yue
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/09/30
ADCC
affinity maturation
antibody engineering
anti-GD2 antibodies
engineered Fc domain
humanized
Trastuzumab in combination with PEGylated interferon-alpha 1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity
期刊论文
OAI收割
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 2, 页码: 549-561
作者:
Xu, Piaopiao
;
Chen, Xiangling
;
Xu, Yongping
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:180/0
  |  
提交时间:2022/06/15
Trastuzumab
PEGylated IFN-alpha 1b
ADCC
HER2-positive cancer
synergistic effect